The bill amends and reenacts various sections of the Uniform Controlled Dangerous Substances Law in Louisiana, specifically targeting Schedules I, IV, and V. It introduces new substances to these schedules, including Zipeprol, Daridorexant, and Ganaxolone, while also adding hallucinogenic plants such as Amanita pantherina. Additionally, the bill updates the structural language regarding the classification of certain stimulant and synthetic cannabinoid compounds, ensuring clarity in their definitions.

Furthermore, the bill repeals a section of Schedule IV that is no longer deemed necessary, streamlining the regulations surrounding controlled substances. The changes include the removal of outdated terminology and the reorganization of substances to maintain alphabetical order, which is intended to enhance the efficiency and effectiveness of the law. Overall, the bill aims to modernize the state's approach to controlled substances and improve public health and safety.

Statutes affected:
SB14 Original: 40:964(S
SB14 Engrossed: 40:964(S
SB14 Enrolled: 40:964(S
SB14 Act : 40:964(S